We have built on a blockchain technology, a model that has the ability to overcome shortage of financing for health, which has been the thorniest issue in global health. Lack of funding for health in many countries of the world has led to increased burden of disease, years of life lost due to illness, very poor quality of life, and quality adjusted life years.
We strive to create a health conscious community that rewards people who people who provide valuable contribution to knowledge in lifescience and health. Through a smart reward system, we will see a rise in emergence of new knowledge and solutions to most vexing issues in health. Ubricoin will reach a broad market for health production that will include millions of people in developing countries who have been excluded from health care and from financial systems.
The use of blockchain in global health is a powerful approach that will build financial incentives for traditionally marginalized hardworking people who contribute knowledge for the betterment of humanity. For the first time, hundreds of millions of people who contribute good deeds to improvement of health related quality of life of human race will receive incentives for the good deeds. This smart reward system will unlock unprecedented amount of funds to support advancement in knowledge in general, and in lifescience and health production in the world, in particular. Good teachers who care deeply about their students, good researchers who contribute to new knowledge and good practitioner who strive to provide greatest quality of service will receive financial incentives for their good deeds.
Our crypto-currency program involves creating incentive programs to reward excellence in education, research and practice. We shall also reward the use of Ubricoin for financial transactions in everyday practice. Buying from local suppliers and manufacturers on Soko Janja will attract rewards. Rewards will help to create incentives for quality in education, research and practice in Africa. Quality of medical and health care will improve in turn.
It is widely documented that people living in developing countries do not have access to good quality education, products of research, and professional services. Much worse, developing countries are not at the forefront of biomedical research, development, innovation, and commercialization of research knowledge into commercial products and services.
The enterprise for translation of science into products for everyday domestic use and clinical care does not exist in many developing countries, because there is no incentive for creating such enterprise. The absence of biomedical and health care innovation has resulted in a huge burden of disease in these countries. Biomedical and health care innovations depend on good financial incentives. The global financial community has not created financial structures to fund biomedical innovation and health production.